Journal article icon

Journal article

Antimicrobial dressings for the prevention of surgical-site infection: systematic review and meta-analysis

Abstract:

Background: Surgical-site infections (SSIs) are a leading cause of postoperative morbidity, prolonged hospitalization, and significant healthcare costs. Antimicrobial dressings may mitigate SSI risk by minimizing local microbial burden, but their effectiveness remains uncertain.

Methods: MEDLINE, Embase, CINAHL, and Cochrane CENTRAL were searched from inception up to 5 July 2024, supplemented by searches of the grey literature and citation chasing. RCTs comparing antimicrobial dressings with any other inert dressing for closed incisional wounds after elective or emergency surgery were included. Data were extracted in duplicate, risk of bias (RoB) was assessed using the Cochrane RoB 2 tool, and certainty of evidence was rated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool. Pairwise random-effects meta-analyses were performed. The primary outcome was SSI within 30 days (90 days if prosthesis used); secondary outcomes included adverse events and costs.

Results: A total of 35 RCTs involving 8718 participants were included. Meta-analyses were conducted for silver (21 studies, 5504 participants), dialkylcarbamoyl chloride (DACC) (3 studies, 892 participants), and mupirocin (3 studies, 1320 participants). Compared with standard dressings, silver dressings reduced the risk of SSI by 22% (risk ratio (RR) 0.78 (95% c.i. 0.62 to 0.97); I2 = 43%; moderate-certainty evidence). DACC dressings halved the risk of SSI (RR 0.49 (95% c.i. 0.29 to 0.83); I2 = 0%; moderate-certainty evidence) compared with standard dressings. Mupirocin dressings were not associated with SSI prevention (RR 0.62 (95% c.i. 0.15 to 2.63); I2 = 67%; very low-certainty evidence). Evidence for other agents was insufficient.

Conclusion: Silver and DACC dressings probably reduce the risk of SSI in closed surgical wounds. There is residual uncertainty over the clinical effectiveness of other antimicrobial dressings.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1093/bjs/znaf277

Authors


More from this funder
Funder identifier:
https://ror.org/03sbpja79


Publisher:
Oxford University Press
Journal:
BJS More from this journal
Volume:
113
Issue:
2
Article number:
znaf277
Publication date:
2026-02-12
Acceptance date:
2025-11-23
DOI:
EISSN:
1365-2168
ISSN:
0007-1323
Pmid:
41677813


Language:
English
Keywords:
Pubs id:
2375984
Local pid:
pubs:2375984
Deposit date:
2026-06-10
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP